Tralokinumab Improves Clinically Relevant Outcome Measures: A Post Hoc Analysis of ECZTRA 3, A Randomized Clinical Trial in Patients with Moderate-To-Severe Atopic Dermatitis

SKIN The Journal of Cutaneous Medicine(2020)

引用 2|浏览3
暂无评分
关键词
atopic dermatitis,clinically relevant outcome measures,ecztra,randomized clinically trial,moderate-to-severe
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要